Sunday 19 October 2025
Home      All news      Contact us      RSS     
wn.com - 2 days ago

Why Hims Hers stock is failing to retain menopause gains and what comes next?

Hims Hers Health Inc (NYSE: HIMS) started this week on a positive note after announcing its expansion into menopause-related treatments – a large and underserved market. However, the rally is fading rather quickly. On Friday, the telehealth stock tanked another 15% as Andrew Dudum, the company’s chief executive, confirmed he’s sold over $11 million worth of its shares. Including today’s decline, Hims Hers stock is down roughly 30% versus its year-to-date high in...


Latest News
Hashtags:   

stock

 | 

failing

 | 

retain

 | 

menopause

 | 

gains

 | 

comes

 | 

Sources